FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5346511000001103: Doxazosin 2mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23058901000001119 Doxazosin 2mg tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
23059001000001112 Doxazosin 2mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxazosin 2mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Is pack of Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Has active ingredient Doxazosin mesilate false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Has VMP Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 30 tablet Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cardura 2mg tablets (PI) (Waymade Ltd) 30 tablet Is a True Doxazosin 2mg tablets 30 tablet Inferred relationship Existential restriction modifier
Cardura 2mg tablets (PI) (Dowelhurst Ltd) 30 tablet Is a True Doxazosin 2mg tablets 30 tablet Inferred relationship Existential restriction modifier
Cardura 2mg tablets (Sigma Pharmaceuticals Plc) 30 tablet Is a True Doxazosin 2mg tablets 30 tablet Inferred relationship Existential restriction modifier
Cardura 2mg tablets (Necessity Supplies Ltd) 30 tablet Is a True Doxazosin 2mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start